CN105939709A - 用于治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(Poly(I:C))制剂 - Google Patents

用于治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(Poly(I:C))制剂 Download PDF

Info

Publication number
CN105939709A
CN105939709A CN201480063745.0A CN201480063745A CN105939709A CN 105939709 A CN105939709 A CN 105939709A CN 201480063745 A CN201480063745 A CN 201480063745A CN 105939709 A CN105939709 A CN 105939709A
Authority
CN
China
Prior art keywords
poly
compositions
starch
pea starch
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480063745.0A
Other languages
English (en)
Chinese (zh)
Inventor
D.M.L.克林格利尔斯
A.H.范迪克
J.门施
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Sciences Ireland ULC
Original Assignee
Janssen Sciences Ireland ULC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland ULC filed Critical Janssen Sciences Ireland ULC
Publication of CN105939709A publication Critical patent/CN105939709A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201480063745.0A 2013-11-06 2014-11-05 用于治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(Poly(I:C))制剂 Pending CN105939709A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13191742.9 2013-11-06
EP13191742 2013-11-06
PCT/EP2014/073762 WO2015067632A1 (en) 2013-11-06 2014-11-05 Polylnosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
CN105939709A true CN105939709A (zh) 2016-09-14

Family

ID=49517426

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480063745.0A Pending CN105939709A (zh) 2013-11-06 2014-11-05 用于治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(Poly(I:C))制剂

Country Status (11)

Country Link
US (1) US20160271165A1 (cg-RX-API-DMAC7.html)
EP (1) EP3065714B1 (cg-RX-API-DMAC7.html)
JP (1) JP6629216B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160072140A (cg-RX-API-DMAC7.html)
CN (1) CN105939709A (cg-RX-API-DMAC7.html)
AU (1) AU2014345667A1 (cg-RX-API-DMAC7.html)
CA (1) CA2929142A1 (cg-RX-API-DMAC7.html)
IL (1) IL245412A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016005883A (cg-RX-API-DMAC7.html)
RU (1) RU2016117398A (cg-RX-API-DMAC7.html)
WO (1) WO2015067632A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118680868A (zh) * 2023-03-24 2024-09-24 清华大学 一种核酸药物递送系统及其制备和应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
HK1251926A1 (zh) * 2015-05-11 2019-05-03 Janssen Sciences Ireland Uc 用於预防和/或治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(聚(i:c))豌豆淀粉制剂
PT3319587T (pt) 2015-11-17 2019-11-20 Bioncotech Therapeutics S L Nova composição farmacêutica que compreende partículas compreendendo um complexo de um polirribonuleótido de cadeia dupla e uma polialquilenoimina
US20200060972A1 (en) 2016-11-16 2020-02-27 Janssen Sciences Ireland Unlimited Company Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
JP2020520368A (ja) * 2017-05-17 2020-07-09 ビオンコテック セラピューティクス エセ.エレ 二本鎖ポリリボヌクレオチドとポリアルキレンイミンとの複合体を含む粒子を含む新規な医薬組成物
KR102123489B1 (ko) 2020-03-13 2020-06-16 주식회사 휴먼셀바이오 자연살해세포 배양액 조성물 및 이를 이용한 자연살해세포 배양방법
US20230338395A1 (en) 2020-04-19 2023-10-26 Ludwig Englmeier Prophylaxis and treatment of coronavirus infection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101124014A (zh) * 2006-01-13 2008-02-13 申益皮卡生物技术有限公司 含基于聚肌苷酸-聚胞苷酸的佐剂的粘膜免疫物质
CN101491503A (zh) * 2008-12-17 2009-07-29 天津瑞普生物技术股份有限公司 一种用于宠物的聚肌胞滴丸及其制备方法
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102488703A (zh) * 2011-12-15 2012-06-13 天津济命生生物科技有限公司 一种聚肌胞制剂的制备方法和抗肿瘤的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101124014A (zh) * 2006-01-13 2008-02-13 申益皮卡生物技术有限公司 含基于聚肌苷酸-聚胞苷酸的佐剂的粘膜免疫物质
CN101491503A (zh) * 2008-12-17 2009-07-29 天津瑞普生物技术股份有限公司 一种用于宠物的聚肌胞滴丸及其制备方法
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102488703A (zh) * 2011-12-15 2012-06-13 天津济命生生物科技有限公司 一种聚肌胞制剂的制备方法和抗肿瘤的用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
姚日生: "《药用高分子材料》", 30 April 2008, 化学工业出版社 *
王国建、刘琳: "《功能高分子材料》", 31 January 2010, 同济大学出版社 *
王国建、刘琳: "《特种与功能高分子材料》", 31 October 2004, 中国石化出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118680868A (zh) * 2023-03-24 2024-09-24 清华大学 一种核酸药物递送系统及其制备和应用

Also Published As

Publication number Publication date
JP2016535094A (ja) 2016-11-10
WO2015067632A1 (en) 2015-05-14
US20160271165A1 (en) 2016-09-22
AU2014345667A1 (en) 2016-05-19
EP3065714B1 (en) 2020-02-12
EP3065714A1 (en) 2016-09-14
CA2929142A1 (en) 2015-05-14
KR20160072140A (ko) 2016-06-22
MX2016005883A (es) 2016-08-17
RU2016117398A3 (cg-RX-API-DMAC7.html) 2018-08-22
RU2016117398A (ru) 2017-12-11
JP6629216B2 (ja) 2020-01-15
IL245412A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
US10485816B2 (en) Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
EP3065714B1 (en) Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
KR20150102995A (ko) 경비 인플루엔자 백신 조성물
US8709496B2 (en) Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
TW201705963A (zh) 用於預防及/或治療上呼吸道感染之聚肌胞苷酸(poly(i:c))豌豆澱粉調配物
US20200060972A1 (en) Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
HK1228749A1 (en) Polyinosinic-polycytidylic acid (poly (i:c) formulations for the treatment of upper respiratory tract infections
HK1203390B (en) Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1228749

Country of ref document: HK

CB03 Change of inventor or designer information

Inventor after: D.M.L.Klingleys

Inventor after: A.H.Van Dyk

Inventor after: J.Menshi

Inventor after: B.A.Malcolm

Inventor before: D.M.L.Klingleys

Inventor before: A.H.Van Dyk

Inventor before: J.Menshi

CB03 Change of inventor or designer information
RJ01 Rejection of invention patent application after publication

Application publication date: 20160914

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1228749

Country of ref document: HK